Christos Argyropoulos MD, PhD on Nostr: The interesting findings of the long term follow up of the metformin in acute covid ...
The interesting findings of the long term follow up of the metformin in acute covid trial:
1st metformin, when started early during acute covid, ⬇️the risk of long covid (LC) by 40%.
2nd the incidence of LC : 6-10% in a mostly vaxx'd population
3rd: invermectin didn't work.
Published at
2024-01-21 02:40:01Event JSON
{
"id": "085bd562735ca45998e7c3372ae9afc871f27a69c07000b7c3adf937dfda89d8",
"pubkey": "9b996b6e3bf76d21fb996af546496affe3be41e14544570189fb7186dff2541c",
"created_at": 1705804801,
"kind": 1,
"tags": [
[
"proxy",
"https://mastodon.social/users/ChristosArgyrop/statuses/111791623489394671",
"activitypub"
]
],
"content": "The interesting findings of the long term follow up of the metformin in acute covid trial:\n1st metformin, when started early during acute covid, ⬇️the risk of long covid (LC) by 40%.\n2nd the incidence of LC : 6-10% in a mostly vaxx'd population\n3rd: invermectin didn't work.",
"sig": "449262ed7ec1e95e2230ade12bcb4c99655e4aaa5aede420a5c62d6d2a27f28dc5dec0939d358b89a60c5285d7f8f1ee8fd2a0c19400dc6ab3e3c83e0c4a28a4"
}
